News & events
Press Releases
On the 28th March 2022, OncoArendi changed its name to Molecure
OncoArendi continues to grow by executing further steps of the strategy and initiates two new drug discovery programs within its existing research platforms
19 August 2021
Galapagos informed about the initiation of a clinical trial to evaluate potential pharmacokinetic interactions of GLPG4716
21 July 2021
OncoArendi executes the strategy for 2021-2025 in the area of R&D platform for developing small molecules modulating RNA function
16 June 2021
OncoArendi and Galapagos enter into exclusive collaboration on chitinase inhibitors in fibrosis
5 November 2020
American Journal of Medicinal Chemistry distinguishes OncoArendi publication on OATD-01
21 October 2020
OncoArendi Therapeutics expands the therapeutic potential of its Chitinase Platform
13 October 2020
Events & Presentations
Fibrosis and Tissue Repair: From Molecules and Mechanics to Therapeutic Approaches – February 19-23, 2020 | Victoria, BC, Canada
27 February 2020
ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA
4 September 2019
EFMC – YMCS – Young Medicinal Chemist Symposium – Ljubljana 02-06.09.2018
17 September 2018